Xenon Pharmaceuticals

XENE · NASDAQ

$36.27+$1.19 (+3.39%)TodayMarket closed · Oct 20, 7:40 PM ET

Prev close $35.08

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 358 full-time employees. The company went IPO on 2014-10-17. The firm is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the advanced, clinically validated potassium channel modulator in late-stage clinical development for the treatment of multiple indications that include epilepsy, including focal onset seizures (FOS), and primary generalized tonic-clonic seizures (PGTCS), as well as neuropsychiatric disorders including major depressive disorder (MDD), and bipolar depression (BPD). The firm is evaluating multiple therapeutic candidates targeting Kv7, Nav1.7, and Nav1.1 across various indications.

Employees: 364
Headquarters: Vancouver, British Columbia
Listed: Oct 17, 2014
Sector: Health Care
Industry: Biotechnology
Website: xenon-pharma.com

Leadership

Xenon Pharmaceuticals executives
Name	Title	Since	Age
Dawn Svoronos	—	—	71
Ian Mortimer	—	2013	49
Thomas Kelly	—	—	54
Darren Cline	—	—	60
Christopher Kenney	—	—	54
Andrea Difabio	—	—	56
Gillian Cannon	—	—	61
Steven Gannon	—	—	63
Elizabeth Garofalo	—	—	67
Justin Gover	—	—	54
Patrick Machado	—	—	61
Gary Patou	—	—	66

Revenue by product and region

Fiscal year ended Mar 31, 2020: $7.08M total revenue

By product

Collaboration Revenue [Member]$7.08M100.0%
Collaboration Revenue [Member]$5.76M81.4%
Collaboration Revenue [Member]$1.23M17.4%
Collaboration Revenue [Member]$83.00K1.2%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Xenon Pharmaceuticals suppliers and customers
Company	Relationship	Country	Correlation
Pacira Biosciences PCRX	Supplier and customer	US	0.38
Neurocrine Biosciences NBIX	Supplier and customer	US	-0.19
Darktrace DARK.L	Supplier	GB	-0.37
Flexion Therapeutics, Inc. FLXN	Supplier and customer	US	-0.78
Icah School of Medicine at Mount Sinai	Supplier and customer	US	—

Similar companies

Companies in the same industry as Xenon Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.